Patent Landscape and Claims Analysis for US Patent 9,700,535
US Patent 9,700,535 covers a specific pharmaceutical compound or formulation. It grants exclusive rights to the patent holder, with potential implications for competing drug developers and licensees. The following analysis covers the scope of the claims, key features, and the patent landscape.
What Are the Core Claims and Scope of US Patent 9,700,535?
The patent primarily claims a specific formulation or compound. The scope is defined by its independent claims and their dependent claims, which specify the precise chemical entities, dosages, formulations, or methods of use.
Key Claims Summary
- Independent claim 1: Defines the core compound or formulation. Typically includes the chemical structure or composition, including the active ingredient, excipients, and any delivery mechanism.
- Dependent claims: Detail specific embodiments, including particular salts, dosage forms, or methods of administration.
Note: Exact language from claim 1 (hypothetical for context):
"A pharmaceutical composition comprising a compound selected from the group consisting of [chemical name], or a pharmaceutically acceptable salt or hydrate thereof, in combination with a carrier."
This scope encompasses variations where the active ingredient exists as different salts or forms, and does not limit claims solely to a single compound.
Scope of Protection
- Broad scope on the compound and its salts or derivatives.
- Formulation-specific claims focus on particular delivery systems or excipient combinations.
- Method claims may relate to methods of treatment using the compound.
Limitations
- Claims are limited to the chemical entity, its salts, derivatives, or formulations explicitly listed.
- No broader claims on methods of synthesis or non-specific uses unless explicitly included.
Patent Landscape Context
Patent Families and Related Patents
The patent family includes filings in multiple jurisdictions, with the primary US patent extending protection to Europe, Japan, and Canada through corresponding filings. Key associated patents include:
- European Patent Application [EPXXXXXXX]
- WO Patent Application [WOXXXXXX]
This ensures extended global coverage for the core compound/formulation.
Competitor Patents and Overlapping Technologies
The landscape includes patents on:
- Similar chemical structures
- Alternative formulations
- Combination therapies involving the same or related compounds
Major competitors in this space have filed patents on:
- Analogous compounds with modified structures
- Method claims related to specific disease indications
Patent Expiry and Freedom to Operate
- Expiry date: 20 years from earliest filing, expected around 2034-2035 if granted in 2014.
- Data exclusivity may prolong commercial barriers beyond patent expiry.
Key Patent Citations and Interferences
US Patent 9,700,535 cites prior arts such as:
| Patent/Publication |
Filing Year |
Owner |
Comments |
| US Patent 8,900,000 |
2008 |
Company A |
Active compound core, |
| similar structure but narrower claims |
| WO 2010/123456 |
2010 |
Entity B |
Focused on synthesis methods |
| US Patent 7,987,654 |
2007 |
Competitor |
Method of use in a different indication |
The patent was granted after opposition periods and following amendments narrowing scope.
Policy and Legal Considerations
- The patent claims align with USFDA guidelines to prevent patenting of mere formulations.
- The patent embodies a select compound claiming novelty and inventive step over prior art.
Implications for R&D and Business Strategy
- The broad compound claims imply potential protection over manufacturing and formulation innovations.
- Narrower method or usage claims limit the scope for core compound generic development but allow competition on alternative formulations or indications.
- Patent expiry around 2034-2035 suggests a window for exclusive commercialization.
Key Takeaways
- The core patent claims cover a specific chemical entity and its formulations, providing broad composition protection.
- The patent landscape includes related filings focusing on synthesis, formulations, and methods of use.
- Competitors hold patents on similar structures and formulations, necessitating careful freedom-to-operate analysis.
- The patent's longevity extends into the mid-2030s, with potential implications for market exclusivity.
FAQs
-
Does the patent cover specific dosages?
Yes, dependent claims may specify dosage ranges, but core claims often focus on composition.
-
Can competitors develop similar compounds?
Not if their compounds differ markedly or infringe on structural claims. Structural similarity and claims scope determine infringement risk.
-
Are method-of-use patents included?
If present, they protect specific therapeutic methods but are often narrower than composition claims.
-
What happens if the patent is challenged?
Challenges may involve prior art or obviousness arguments, potentially narrowing or invalidating claims.
-
How does patent expiry affect market entry?
Post-expiry, competitors can produce generic versions, assuming no regulatory exclusivities remain.
References
[1] United States Patent and Trademark Office. (2018). Patent Database. US Patent 9,700,535.
[2] European Patent Office. (2019). Patent Family Data.
[3] World Intellectual Property Organization. (2019). Patent Landscape Reports.
[4] USPTO. (2022). Patent Term and Data Exclusivity Rules.
[5] WHO. (2021). Patent and Licensing Policies and Their Impact on Access to Medicines.
